Dicyclomine Hydrochloride + SimethiconeThird Party Manufacturing in India

Dicyclomine Hydrochloride + Simethicone works by combining an anticholinergic antispasmodic agent with a defoaming surfactant to alleviate abdominal spasms and gas-related discomfort.

Dicyclomine Hydrochloride binds to and blocks muscarinic cholinergic receptors on smooth muscle cells within the gastrointestinal tract, preventing acetylcholine from inducing contractions. This blockade helps the body reduce painful intestinal spasms and cramping. Simethicone operates locally in the gut lumen by lowering the surface tension of gas bubbles, causing them to coalesce into larger, easily passing bubbles. This physical action facilitates the elimination of entrapped gas, relieving bloating and pressure.

Unlike standard single-agent antispasmodics, Dicyclomine Hydrochloride + Simethicone targets the dual root causes of abdominal colic: smooth muscle spasms and gas accumulation. It is highly effective and well-tolerated for pediatric patients suffering from infantile colic and adults experiencing irritable bowel syndrome.

Therapeutic Uses

Dicyclomine Hydrochloride + Simethicone is prescribed for the treatment of:

• Infantile Colic: Relieves acute abdominal pain and spasms in infants caused by trapped gas and immature digestive systems.
• Irritable Bowel Syndrome (IBS): Manages symptoms of abdominal pain, bloating, and cramping associated with hypermotility and flatulence.
• Functional Bowel Disorders: Alleviates spasmodic pain, abdominal distension, and general gastrointestinal discomfort.

Why Manufacturers Choose Dicyclomine Hydrochloride + Simethicone

Dicyclomine Hydrochloride + Simethicone is a highly commercial combination due to its extensive use in pediatric and gastroenterology practices. Abdominal colic and gas are universal, high-frequency complaints, ensuring steady year-round retail demand for oral drops and liquid emulsions. Sourcing this combination from WHO-GMP certified facilities allows pharmaceutical brands to offer highly stable, palatable liquid formulations with long shelf lives. The established clinical safety and low production costs make it a staple product for PCD franchise catalogs and export distributors targeting markets in Asia, Africa, and Latin America.

This makes Dicyclomine Hydrochloride + Simethicone one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.